# Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma

> **NCT00539643** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 101 (actual)

## Conditions studied

- Hepatocellular Carcinoma
- Liver Cancer
- Hepatoma

## Interventions

- **DEVICE:** Bead Block microspheres
- **OTHER:** Bead + Dox Arm

## Key facts

- **NCT ID:** NCT00539643
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2022-06-17
- **Final completion:** 2022-06-17
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2023-08-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00539643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00539643, "Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00539643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*